Bioequivalence of Lisihexal® tablet to Zestril® tablet(Lisinopril 10 mg) |
Oh, Soo-Yeon
(Department of Pharmacology, College of Medicine, Dankook University)
Aryal Dipendra Kumar (Department of Pharmacology, College of Medicine, Dankook University) Cho, Jong-Tae (Department of Internal Medicine, College of Medicine, Dankook University) Kim, Hyung-Gun (Department of Pharmacology, College of Medicine, Dankook University) Kim, Yoon-Gyoon (Department of Pharmacology, College of Medicine, Dankook University) |
1 | 식품의약품안전청 고시 제 2002-60호(2002. 11. 22). 생물학적동등성시험 기준 |
2 | M. Georgarakis, A. Tsakalof, F. Zougrou, G. Kontopoulos and I. Tsiptsios, Evaluation of the bioequivalence and pharmacokinetics of two lisinopril tablet formulations after single oral administration in healthy volunteers, Arzneimittel- forschung, 54(1), 15-19 (2004) |
3 | A.A.F. Padua, R.E. Barrientos-Astigarraga, V.M. Rezende, G.D. Mendes and G. De Nucci, Lisinopril quantification in human plasma by liquid chromatography-electrospray tandem mass spectrometry, J. Chromatogr. B, 809, 211-216 (2004) DOI ScienceOn |
4 | S.C. Sweetman (Ed.), Martindale, The complete drug reference, 33th ed, Pharmaceutical Press. London, U.K., pp. 921 (2002) |
5 | A.R. Gascon, A. Cuadrado, M.A. Solinis, R.M. Hernandez, E. Ramirez, R. Dalmau and J.L. Pedraz, Comparative bioavailability of two immediate-release tablets of lisinopril/hydrochlorothiazide in healthy volunteers, Int. J. Clin. Pharmacol. Ther., 41, 309-315 (2003) DOI |
6 | A.S. Yuan and J.D. Gilbert, Time-resolved fluoroimmuno- assay for the determination of lisinopril and enalaprilat in human serum, J. Pharm. Biomed. Anal., 14(7), 773-781 (1996) DOI ScienceOn |
7 | Y.C. Wong and B.G. Charles, Determination of the angio- tensin-converting enzyme inhibitor lisinopril in urine using solid-phase extraction and reversed-phase high-performance liquid chromatography, J. Chromatogr. B, 673(2), 306-310 (1995) DOI ScienceOn |
8 | A. Tsakalof, K. Bairachtari and M. Georgarakis, Develop- ment of a liquid chromatography-mass spectrometry method for monitoring the angiotensin-converting enzyme inhibitor lisinopril in serum, J. Chromatogr. B, 783, 425-432 (2003) DOI ScienceOn |
9 | H.J. Leis, G. Fauler, G. Raspotnig and W. Windischhofer, An improved method for the measurement of the angiotensin-converting enzyme inhibitor lisinopril in human plasma by stable isotope dilution gas chromatography/negative ion chemical ionization mass spectrometry, Rapid Commun. Mass Spectrom., 13(8), 650-653 (1999) DOI ScienceOn |
10 | 생물학적동등성시험 표준지침, 식품의약품안전청 국립독성연구원, pp. 30-34 (2003) |
11 | P.J. Worland and B. Jarrott, Radioimmunoassay for the quantitation of lisinopril and enalaprilat, J. Pharm. Sci., 75(5), 512-516 (1986) DOI |
12 | O. Sgirli and L. Ersoy, An HPLC method for the determination of lisinopril in human plasma and urine with fluorescence detection, J. Chromatogr. B, 809, 159-165 (2004) DOI ScienceOn |